Literature DB >> 1656772

Characterization of the synergistic interaction of Escherichia coli heat-stable toxin and carbachol.

S A Levine1, M Donowitz, A J Watson, G W Sharp, J K Crane, C S Weikel.   

Abstract

STa, the heat-stable enterotoxin of Escherichia coli, is a specific activator of membrane-bound guanylyl cyclase and stimulates secretion of Cl- in a human colonic carcinoma cell line (T84). We investigated the effect of the cholinergic agent carbachol on the secretory response to STa. T84 cell monolayers were studied under voltage-clamped conditions in modified Ussing chambers. Simultaneous addition of STa and carbachol resulted in a biphasic synergistic response characterized by a brief peak in short-circuit current (Isc) followed by a prolonged plateau phase lasting up to 90 min. A synergistic response was also seen with sequential addition of the agonists, and was altered by the order and timing of agonist addition. Pretreatment with STa enhanced the synergistic response to carbachol, while the reverse order of additions produced synergy only when STa was added during or immediately after the Isc response to carbachol. Synergy occurred only with a concentration of STa sufficient to produce an Isc response alone. However, a concentration of carbachol that caused neither an increase in Isc nor intracellular Ca2+ mobilization was sufficient to evoke a synergistic response. Addition of 8-bromoguanosine 3',5'-cyclic monophosphate also produced a synergistic Isc response with carbachol, although maximal synergism was seen with simultaneous addition. Augmentation of the intracellular Ca2+ response to carbachol by STa is not the mechanism of synergy. Although the mechanism of synergy is not understood, these studies suggest that STa-induced cGMP interacts with other second messengers to produce the synergistic response, and that multiple intracellular mediators may influence the ability of STa to cause disease.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1656772     DOI: 10.1152/ajpgi.1991.261.4.G592

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  12 in total

Review 1.  Enteric bacterial toxins: mechanisms of action and linkage to intestinal secretion.

Authors:  C L Sears; J B Kaper
Journal:  Microbiol Rev       Date:  1996-03

2.  Psyllium improves fecal consistency and prevents enhanced secretory responses in jejunal tissues of piglets infected with ETEC.

Authors:  U L Hayden; S M McGuirk; S E West; H V Carey
Journal:  Dig Dis Sci       Date:  1998-11       Impact factor: 3.199

3.  Rapid non-genomic activation of cytosolic cyclic AMP-dependent protein kinase activity and [Ca(2+)](i) by 17beta-oestradiol in female rat distal colon.

Authors:  C M Doolan; S B Condliffe; B J Harvey
Journal:  Br J Pharmacol       Date:  2000-04       Impact factor: 8.739

Review 4.  Pathogenesis of human enterovirulent bacteria: lessons from cultured, fully differentiated human colon cancer cell lines.

Authors:  Vanessa Liévin-Le Moal; Alain L Servin
Journal:  Microbiol Mol Biol Rev       Date:  2013-09       Impact factor: 11.056

5.  Activation of host cell protein kinase C by enteropathogenic Escherichia coli.

Authors:  J K Crane; J S Oh
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

6.  Bacteroides fragilis toxin exhibits polar activity on monolayers of human intestinal epithelial cells (T84 cells) in vitro.

Authors:  F G Chambers; S S Koshy; R F Saidi; D P Clark; R D Moore; C L Sears
Journal:  Infect Immun       Date:  1997-09       Impact factor: 3.441

7.  Guanylin stimulation of Cl- secretion in human intestinal T84 cells via cyclic guanosine monophosphate.

Authors:  L R Forte; S L Eber; J T Turner; R H Freeman; K F Fok; M G Currie
Journal:  J Clin Invest       Date:  1993-06       Impact factor: 14.808

8.  Mutual enhancement of virulence by enterotoxigenic and enteropathogenic Escherichia coli.

Authors:  John K Crane; Shilpa S Choudhari; Tonniele M Naeher; Michael E Duffey
Journal:  Infect Immun       Date:  2006-03       Impact factor: 3.441

9.  Human colonic epithelial cells, HT29/C1, treated with crude Bacteroides fragilis enterotoxin dramatically alter their morphology.

Authors:  C S Weikel; F D Grieco; J Reuben; L L Myers; R B Sack
Journal:  Infect Immun       Date:  1992-02       Impact factor: 3.441

10.  Diarrhea or colorectal cancer: can bacterial toxins serve as a treatment for colon cancer?

Authors:  S L Carrithers
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-11       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.